Cleidocranial dysplasia with a rare mutation: Study of a family with review of literature


Introduction: The present study was aimed at advancing the understanding of the pathogenesis of cleidocranial dysplasia (CCD) by presenting a case study based on history, physical examination, typical radiological features, and molecular analysis and a review of the literature. Methods: This study began with a 23-year-old boy (proband) who was referred to the department of oral and maxillofacial radiology with chief complaint of the upper-left first molar tooth and routine dental examination. While evaluating the panoramic radiograph, the patient had approximately 57 teeth in his both of the jaws. Clinical, radiographical and molecular features of the proband, two siblings and their parents were examined and then, DNA analysis was performed. Results: Overall, we present 3 CCD patients with a mutation in the VWRPY motif. The deletion of c. 1754_1757 delTTTG (NM_001024630.2) is determined and it leads to a frame shift mutation and stop codon, p. V585Gfs56X. Conclusions: The present study emphasized the importance of further clinical and molecular investigation when even a single case of CCD is identified within a family. This is the first study performed in Turkey about a family with a mutation in the VWRPY motif. Genotype-phenotype association studies in individuals with CCD are necessary to provide important insights into molecular mechanisms associated with this disease.

Share and Cite:

Sekerci, A. , Balta, B. , Bahadir, O. , Sisman, Y. , Dundar, M. , Tokmak, T. and Mundlos, S. (2013) Cleidocranial dysplasia with a rare mutation: Study of a family with review of literature. Open Journal of Stomatology, 3, 402-410. doi: 10.4236/ojst.2013.38068.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Marie, P. and Sainton P. (1898) Sur la dysostose cleidocranienne hereditaire. Revista de Neurología, 6, 835-838.
[2] Mundlos, S. (1999) Cleidocranial dysplasia: Clinical and molecular genetics. Journal of Medical Genetics, 36, 177-182.
[3] Quack, I., Vonderstrass, B., Stock, M., Aylsworth. A.S., Becker, A., Brueton. L., et al. (1999) Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. The American Journal of Human Genetics, 65, 1268-1278.
[4] Figueroa, A.A. and Friede, H. (2000) Craniofacial growth in unoperated craniofacial malformations. The Cleft Palate—Craniofacial Journal, 37, 431-432.<0431:CGIUCM>2.0.CO;2
[5] Counts, A.L., Rohrer, M.D., Prasad, H. and Bolen, P., (2001) An assessment of root cementum in cleidocranial dysplasia. The Angle Orthodontist, 71, 293-298.
[6] Roberts, T., Stephen, L. and Beighton, P. (2013) Cleidocranial dysplasia: A review of the dental, historical, and practical implications with an overview of the South African experience. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 115, 46-55.
[7] Dalessandri, D., Laffranchi, L., Tonni, I., Zotti, F., Piancino, M.G., Paganelli, C., et al. (2011) Advantages of cone beam computed tomography (CBCT) in the orthodontic treatment planning of cleidocranial dysplasia patients: A case report. Head & Face Medicine, 27, 6.
[8] Mohan, R.P., Suma, G.N., Vashishth, S. and Goel, S. (2010) Cleidocranial dysplasia: Clinico-radiological illustration of a rare case. Journal of Oral Science, 52, 161-166.
[9] Mundlos, S., Otto, F., Mundlos, C., Mulliken, J.B., Aylsworth, A.S., Albright, S., et al. (1997) Mutations involveing the transcription factor CBFA1 cause cleidocranial dysplasia. Cell, 89, 773-779.
[10] Li, Y.L. and Xiao, Z.S. (2007) Advances in Runx2 regulation and its isoforms. Medical Hypotheses, 68, 169-175.
[11] Shen, Z., Zou, C.C., Yang, R.W. and Zhao, Z.Y. (2009) Cleidocranial dysplasia: Report of 3 cases and literature review. Clinical Pediatrics, 48, 194-198.
[12] Li, Y., Pan, W., Xu, W., He, N., Chen, X., Liu, H., et al. (2009) RUNX2 mutations in Chinese patients with cleidocranial dysplasia. Mutagenesis, 24, 425-431.
[13] Zhang, C., Zheng, S., Wang, Y., Zhao, Y., Zhu, J. and Ge, L. (2010) Mutational analysis of RUNX2 gene in Chinese patients with cleidocranial dysplasia. Mutagenesis, 25, 594.
[14] Wang, G.X., Sun, R.P. and Song, F.L. (2010) A novel RUNX2 mutation (T420I) in Chinese patients with cleidocranial dysplasia. Genetics and Molecular Research, 9, 41-47.
[15] Fang, C.Y., Xue, J.J., Tan, L., Jiang, C.H., Gao, Q.P., Liang, D.S. and Wu, L.Q. (2011) A novel single-base deletion mutation of the RUNX2 gene in a Chinese family with cleidocranial dysplasia. Genetics and Molecular Research, 10, 3539-3544.
[16] Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., et al. (1993) PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1 gene. Proceedings of the National Academy of Sciences, 90, 6859-6863.
[17] Yoshida, T., Kanegane, H., Osato, M., Yanagida, M., Miyawak, T., Ito, Y., et al. (2002) Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations. The American Journal of Human Genetics, 71, 724-738.
[18] Chen, G. and Courey, A.J. (2000) Groucho/TLE family proteins and transcriptional repression. Gene, 249, 1-16.
[19] Levanon, D., Goldstein, R.E., Bernstein, Y., Tang, H., Goldenberg, D., Stifani, S., et al. (1998) Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proceedings of the National Academy of Sciences, 95, 11590-11595.
[20] Golan, I., Baumert, U., Hrala, B.P. and Mussig, D. (2003) Dentomaxillofacial variability of cleidocranial dysplasia: clinicoradiological presentation and systematic review. Dentomaxillofacial Radiology, 32, 347-354.
[21] Quinn, P.D., Lewis, J. and Levin, L. (1992) Surgical management of a patient with cleidocranial dysplasia: A case report. Special Care Dentistry, 12, 131-133.
[22] Alves, N. and De Caso, R. (2008) Cleidocranial dysplasia—A case report. International Journal of Morphology, 26, 1065-1068.
[23] Fukuta, Y., Totsuka, M., Fukuta, Y., Takeda, Y., Yoshida, Y., Niitsu, J., et al. (2001) Histological and analytical studies of a tooth in a patient with Cleidocranial dysplasia. Journal of Oral Science, 43, 85-89.
[24] McNamara, C.M., O’Riordan, B.C., Blake, M. and Sandy, J.R. (1999) Cleidocranial dysplasia: Radiological appearances on dental panoramic radiography. Dentomaxillofacial Radiology, 28, 89-97.
[25] Winter. G.R. (1943) Dental conditions in cleidocranial dysostosis. American Journal of Orthodontics and Oral Surgery, 29, 61-89.
[26] Jensen, B.L. and Kreiborg, S. (1990) Development of the dentition in cleidocranial dysplasia. Journal of Oral Pathology & Medicine, 19, 89-93.
[27] Kalliala, E. and Taskinen, P.J. (1962) Cleidocranial dysostosis: Report of six typical cases and one atypical case. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 14, 808.
[28] Goto, T., Aramaki, M., Yoshihashi, H., Nishimura, G., Hasegawa, Y., Takahashi. T., et al. (2004) Large fontanels are a shared features of haploinsufficiency of RUNX2 and its coactivator CBFB. Congenital Anomalies, 44, 225-229.
[29] Becker, A., Lustman, J. and Shteyer, A. (1997) Cleidocranial dysplasia: Part 1-General principles of the orthodontic and surgical treatment modality. American Journal of Orthodontics and Dentofacial Orthopedics, 111, 28-33.
[30] D’Alessandro, G., Tagariello, T. and Piana, G. (2010) Craniofacial changes and treatment of the stomatognathic system in subjects with cleidocranial dysplasia. European Journal of Paediatric Dentistry, 11, 39-43.
[31] Smylski, P.T., Woodside, D.G. and Harnett, B.E. (1974) Surgical and orthodontic treatment of cleidocranial dysostosis. International Journal of Oral Surgery, 3, 380-385.
[32] Hall, R.K. and Hyland, A.L. (1978) Combined surgical and orthodontic management of the oral abnormalities in children with cleidocranial dysplasia. International Journal of Oral Surgery, 7, 267-273.
[33] Richardson, A. and Swinson, T. (1987) Combined orthodontic and surgical approach to cleidocranial dysostosis. Transactions European Orthodontic Society, 63, 23.
[34] Behlfelt, K. (1987) Cleido-cranial dysplasia: Diagnosis and treatment concept. Transactions European Orthodontic Society, 63, 25.
[35] Petropoulos, V.C., Balshi, T.J., Balshi, S.F., et al. (2004) Treatment of a patient with cleidocranial dysplasia using osseointegrated implants: A patient report. The International Journal of Oral & Maxillofacial Implants, 19, 282-287.
[36] Kelly, E. and Nakamoto, R.Y. (1974) Cleidocranial dysostosis—A prosthodontic problem. Journal of Prosthetic Dentistry, 31, 518-526.
[37] Daskalogiannakis, J., Piedade, L., Lindholm, T.C., Sándor, G.K. and Carmichael, R.P. (2006) Cleidocranial Dysplasia: 2 Generations of management. Journal of the Canadian Dental Association, 72, 337-342.
[38] Sato, K., Sugawara, J., Mitani, H. and Kawamura, H. (1998) Use of selectively colored stereolithography for diagnosis of impacted supernumerary teeth for a patient with cleidocranial dysplasia. The International Journal of Adult Orthodontics & Orthognathic Surgery, 13, 163-167.
[39] Golan, I., Preising, M., Wagener, H., Baumert, U., Niederdellmann, H., Lorenz, B. and Mussig, D. (2000) A novel missense mutation of the CBFA1 gene in a family with cleidocranial dysplasia (CCD) and variable expressivity. Journal of Craniofacial Genetics and Developmental Biology, 20, 113-120.
[40] Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., et al. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell, 89, 755-764.
[41] Okuda, T., van Deursen, J., Hiebert, S.W., Grosveld, G. and Downing, J.R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell, 84, 321-330.
[42] Speck, N.A., Stacy, T., Wang, Q., North, T., Gu, T.L., Miller, J., Binder, M., et al. (1999) Core-binding factor: A central player in hematopoiesis and leukemia. Cancer Research, 59, 1789-1793.
[43] Thirunavukkarasu, K., Mahajan, M., McLarren, K.W., Stifani, S. and Karsenty, G. (1998) Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta. Molecular and Cellular Biology, 18, 4197-4208.
[44] Kanno, T., Kanno, Y., Chen, L.F., Ogawa, E., Kim, W.Y. and Ito, Y. (1998) Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit. Molecular and Cellular Biology, 18, 2444-2454.
[45] Zhang, Y.W., Yasui, N., Ito, K., Huang, G., Fuji, M., Hanai, J., et al. (2000) A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proceedings of the National Academy of Sciences, 7, 10549-10554.
[46] Aronson, B.D., Fisher, A.L., Blechman, K., Caudy, M. and Gergen, J.P. (1997) Groucho-dependent and independent repression activities of Runt domain proteins. Molecular and Cellular Biology, 17, 5581-5587.
[47] Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y. and Ohki, M. (1991) t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proceedings of the National Academy of Sciences, 88, 10431-10434.
[48] Nucifora, G., Birn, D.J, Erickson. P., Gao, J., LeBeau, M.M., Drabkin, H.A., et al. (1993) Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood, 81, 883-888.
[49] Napierala, D., Garcia-Rojas, X., Sam, K., Wakui, K., Chen, C., Mendoza-Londono, R., et al. (2005) Mutations and promoter SNPs in RUNX2, a transcriptional regulator of bone formation. Molecular Genetics and Metabolism, 86, 257-268.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.